IP Library Granted Patent US 9,856,240
Granted Patent B2
US 9,856,240 · App. 14/353,285 · Granted Jan 2, 2018

Compounds that modulate intracellular calcium

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,856,240
App. No.
14/353,285
Granted
Jan 2, 2018
Kind
B2
Abstract

Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Claims (29)

1. A compound having the structure of Formula (I):

wherein:

X is CH or N;

R 1 is Cl or CH 3 ;

each R 2 is independently selected from halogen, C 1 -C 6 alkyl, and C 1 -C 6 haloalkyl;

R 3 is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 3 -C 8 cycloalkyl;

m is an integer selected from 0-3;

n is an integer selected from 0-2;

p is an integer selected from 1-2;

or a pharmaceutically acceptable salt, or pharmaceutically acceptable solvate thereof.

2. The compound of claim 1 wherein X is CH.

3. The compound of claim 2 wherein A is

4. The compound of claim 3 wherein n is 1.

5. The compound of claim 4 wherein R 2 is C 1 -C 6 alkyl.

6. The compound of claim 4 wherein R 2 is halogen.

7. The compound of claim 3 wherein n is 2.

8. The compound of claim 7 wherein each R 2 is independently selected from halogen, C 1 -C 6 alkyl, and C 1 -C 6 haloalkyl.

9. The compound of claim 8 wherein each R 2 is independently selected from Cl, CH 3 , and CF 3 .

10. The compound of claim 3 wherein R 3 is C 1 -C 6 alkyl.

11. The compound of claim 1 wherein X is N.

12. The compound of claim 11 wherein A is

13. The compound of claim 12 wherein n is 1.

14. The compound of claim 13 wherein R 2 is C 1 -C 6 alkyl.

15. The compound of claim 13 wherein R 2 is halogen.

16. The compound of claim 12 wherein n is 2.

17. The compound of claim 16 wherein each R 2 is independently selected from halogen, C 1 -C 6 alkyl, and C 1 -C 6 haloalkyl.

18. The compound of claim 17 wherein each R 2 is independently selected from Cl, CH 3 , and CF 3 .

19. The compound of claim 12 wherein R 3 is C 1 -C 6 alkyl.

20. A pharmaceutical composition comprising a pharmaceutically acceptable diluent, excipient or binder, and a compound of claim 1 or a pharmaceutically acceptable salt, or pharmaceutically acceptable solvate thereof.

Assignments (2)
SECURITY INTEREST Recorded Mar 4, 2025
From: CALCIMEDICA, INC.
To: AVENUE CAPITAL MANAGEMENT II, L.P.
Reel/Frame 070394/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2015
From: CAO, JIANGUO; WHITTEN, JEFFREY P.; WANG, ZHIJUN; ROGERS, EVAN; GREY, JONATHAN
To: CALCIMEDICA, INC.
Reel/Frame 035920/0737 →